Liver metastasis caused by the CD63-BCAR4 fusion gene was also reduced in canertinib-treated mice, although the difference did not reach statistical significance ( Figure 5B ).
← all excerpts
Oncogenic fusion of BCAR4 activates EGFR signaling and is sensitive to dual inhibition of EGFR/HER2.
1
—
—